CareDx Inc CDNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:54 PM EST
42.46quote price arrow up+0.09 (+0.21%)
Volume
273,331
52 week range
39.16 - 99.83
Loading...
  • Open42.92
  • Day High43.06
  • Day Low40.76
  • Prev Close42.37
  • 52 Week High99.83
  • 52 Week High Date01/20/21
  • 52 Week Low39.16
  • 52 Week Low Date11/23/21

Key Stats

  • Market Cap2.235B
  • Shares Out52.63M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-41.5

KEY STATS

  • Open42.92
  • Day High43.06
  • Day Low40.76
  • Prev Close42.37
  • 52 Week High99.83
  • 52 Week High Date01/20/21
  • 52 Week Low39.16
  • 52 Week Low Date11/23/21
  • Market Cap2.235B
  • Shares Out52.63M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-41.5

RATIOS/PROFITABILITY

  • EPS (TTM)-0.35
  • P/E (TTM)-122.22
  • Fwd P/E (NTM)258.90
  • EBITDA (TTM)-3.715M
  • ROE (TTM)-2.42%
  • Revenue (TTM)253.60M
  • Gross Margin (TTM)67.96%
  • Net Margin (TTM)-3.53%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/22/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CareDx Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company’s commercially available testing services consist of AlloSure Kidney...
Michael Goldberg
Non-Executive Chairman
Reginald Seeto
President
Ankur Dhingra
Chief Financial Officer
Marcel Konrad CPA
Vice President
Address
1 Tower Place, 9Th Floor
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
GTH
Genetron Holdings Ltd
9.81-0.94-8.74%
NOTV
Inotiv Inc
53.05-2.20-3.99%
FLGT
Fulgent Genetics Inc
98.05+0.47+0.48%
PROG
Progenity Inc
3.19-0.45-12.36%
DMTK
DermTech Inc
20.11+0.42+2.11%